| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/23/2000 | EP0980243A1 Use of high dose retinoids for the treatment of skin disorders |
| 02/23/2000 | EP0980242A2 Use of fumaric acid derivatives |
| 02/23/2000 | EP0980241A1 Gelatine encapsulated solution dosage forms of sertraline |
| 02/23/2000 | EP0980240A1 Sustained-release compositions and method for preparing same |
| 02/23/2000 | EP0980205A1 Method of treating malignancies |
| 02/23/2000 | EP0980204A1 76 kDa, 32 kDa, AND 50 kDa HELICOBACTER POLYPEPTIDES AND CORRESPONDING POLYNUCLEOTIDE MOLECULES |
| 02/23/2000 | EP0980203A1 Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
| 02/23/2000 | EP0898579B1 Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds |
| 02/23/2000 | EP0861252B1 Naphthamide derivatives of 3 beta-amino azabicyclo octane or nonane as neuroleptic agents |
| 02/23/2000 | EP0861226B1 Synthesis of carboxylic acid derivatives |
| 02/23/2000 | EP0832063B1 Vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 02/23/2000 | EP0806933A4 Formulations and methods for reducing skin irritation |
| 02/23/2000 | EP0792268B1 Hypolipidemic benzothiazepines |
| 02/23/2000 | EP0775138B1 TETRAHYDROPYRIDINYLMETHYL DERIVATIVES OF PYRROLO 2,3-b]PYRIDINE |
| 02/23/2000 | CN1245499A 8-azabicyclo [3,2,1] octane, 8-azabicyclo [3,2,1] oct-6-ene-,9-azabicyclo [3,2,1] nonane-, 9-aza-3-oxabicyclo [3,3,1] nonane- and 9-aza-3-thiabicyclo[3,3,1] nonane derivatives, their preparation and |
| 02/23/2000 | CN1245496A 3-pyridyl enantiomers and their use as analgesics |
| 02/23/2000 | CN1245495A N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate |
| 02/23/2000 | CN1245494A New 4-(1-piperazinyl) benzoic acid derivatives, process for preparing them and their therapeutic applications |
| 02/23/2000 | CN1245493A Asymmetric synthesis of benzoxazinones |
| 02/23/2000 | CN1245491A 5-cyclo indole compounds as 5-HT receptor ligands |
| 02/23/2000 | CN1245490A Sulfonyl urea derivatives and their use in control of interleukin-1 activity |
| 02/23/2000 | CN1245486A Ketobenzamides as calpain inhibitors |
| 02/23/2000 | CN1245431A Medical composition and use thereof for manufacture of topical barrir formulation, UV-radiation absorbing formulation, or antiviral, antifungal, or antiinflammatory formulation |
| 02/23/2000 | CN1245430A Prophylactic and therapeutic agent for inflammatory intestinal diseases |
| 02/23/2000 | CN1245429A Leukotriene antagonists for oral squamous cell carcinoma |
| 02/23/2000 | CN1245428A Use of 7-(2-oxa-5,8-diazabicyclo [4,3,0] non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for treatment of helicobacter pylori infections and associated gastroduodenal |
| 02/23/2000 | CN1245427A Use of 1-[4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyrid-1 yl]-2-(6,7-dimethoxynapht-2-yl) ethane for preparing medicines for treatment of cerebral and neuronal disorders |
| 02/23/2000 | CN1245426A Composition containing diarylalkane derivative as active ingredient for treating or preventing pancreatitis |
| 02/23/2000 | CN1245425A Poly(diallylamine)-based bile acid sequestrants |
| 02/23/2000 | CN1245424A Medicinal composition |
| 02/23/2000 | CN1245423A Formulation and method for treating neoplasms by inhalation |
| 02/23/2000 | CN1245169A Nitroketone compound, its preparing process and pharmaceutical composition containing same |
| 02/23/2000 | CN1245168A Amino quinoline derivatives |
| 02/23/2000 | CN1245161A Process for preparing chromium L-threonate, its preparing process and application |
| 02/23/2000 | CN1245074A Medicine for reducing acidity in vegina and its usage |
| 02/23/2000 | CN1245072A Ointment for treating burn and scald and its preparing process |
| 02/23/2000 | CN1245060A Process for preparing medicine or health-care food to effectively lose weight and reduce blood sugar |
| 02/23/2000 | CN1245059A Arginomycin medicine for vagina |
| 02/23/2000 | CN1245058A Antivirus veterinary composition |
| 02/23/2000 | CN1245057A Reversing agent for multi-medicine resistance of tumor cells |
| 02/23/2000 | CN1245056A Solid skin-testing agent of cephalosporins |
| 02/23/2000 | CN1245054A Cosmetics and/or composition for treating skin disease and use thereof |
| 02/23/2000 | CN1049687C The use of polyether ionophore antibiotics to control bacterial growth in alcohol fermentation |
| 02/23/2000 | CN1049670C Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and preparing process |
| 02/23/2000 | CN1049660C Benzopyran compounds, process for their preparation and pharmaceutical compositions containing them |
| 02/23/2000 | CN1049659C Corticotropin releasing factor antagonists |
| 02/23/2000 | CN1049658C Pyrazolo [4,3-c] pyridines, a process for their preparation and their use as 5-serotonin reuptake inhibitors |
| 02/23/2000 | CN1049654C Piperazine derivatives and medicine composition containing same and use thereof |
| 02/23/2000 | CN1049653C Vitamin D3 analogs and pharmaceutical composition containing same |
| 02/23/2000 | CN1049651C Metalloproteinase inhibitors |
| 02/23/2000 | CN1049587C Liniment for warming middle jiao, dispelling cold and analgesia |
| 02/23/2000 | CN1049586C Dressing medicine for treating hyperosteogeny and prepn. method |
| 02/23/2000 | CN1049581C Oral capsule with adsorption of urea-nitrogen |
| 02/23/2000 | CN1049577C Long-acting prodrug of nabufrine analgesic and preparing process thereof |
| 02/23/2000 | CN1049557C Method for controlling parasitic nematodes of plant with pyrrolidine compound |
| 02/22/2000 | US6028223 An integrin antagonists treating bone disorder, periodontal disease, osteoporosis, humoral hypercalcemia of malignancy, paget's disease, tumor angiogenesis, diabetic retinopathy, arthritis, smooth muscle cell migration and restenosis |
| 02/22/2000 | US6028222 Stable liquid paracetamol compositions, and method for preparing same |
| 02/22/2000 | US6028214 GABA and L-glutamic acid analogs for antiseizure treatment |
| 02/22/2000 | US6028207 A tetracycline type antibiotic covalent bonded with a steroid type hormone estrogen has an osteogenesis function in addition to a bone resorption inhibition, can concentrate on the bone tissues |
| 02/22/2000 | US6028198 Pharmaceutical composition for prevention and treatment of motion sickness syndrome |
| 02/22/2000 | US6028197 Dibenzo[a,g]quinolizinium derivatives and the salts thereof |
| 02/22/2000 | US6028195 Piperazine derivatives and process for the preparation thereof |
| 02/22/2000 | US6028182 Methylphosphonic acid esters, processes for their preparation, and their use |
| 02/22/2000 | US6028181 6-0-Substituted antibacterial erythromycin ketolides and methods of making |
| 02/22/2000 | US6028164 Bioresorbable compositions for implantable prostheses |
| 02/22/2000 | US6028116 Substituted condensation products of 1H-indenyl-hydroxyalkanes with aldehydes for neoplasia |
| 02/22/2000 | US6028115 Method for preventing sexually transmitted diseases |
| 02/22/2000 | US6028114 Use of aminothiolester derivatives in pharmaceutics |
| 02/22/2000 | US6028111 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
| 02/22/2000 | US6028110 Succinyl hydroxamic acid, N-formyl-N-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors |
| 02/22/2000 | US6028109 Use of agonists of the peroxisome proliferator activated receptor alpha for treating obesity |
| 02/22/2000 | US6028108 Propofol composition comprising pentetate |
| 02/22/2000 | US6028107 Orthomolecular medical use of L-citrulline for vasoprotection, relaxative smooth muscle tone and cell protection |
| 02/22/2000 | US6028106 Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents |
| 02/22/2000 | US6028105 Topical drug delivery composition and method |
| 02/22/2000 | US6028104 Use of peroxygen compounds in the control of hairy wart disease |
| 02/22/2000 | US6028103 Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation |
| 02/22/2000 | US6028102 Anticonvulsant drugs and pharmaceutical compositions thereof |
| 02/22/2000 | US6028101 Fungicides for the control of take-all disease of plants |
| 02/22/2000 | US6028098 Use of cis-or transurocamic acid for the treatment of photodermatoses and immunogenic skin diseases |
| 02/22/2000 | US6028097 Method of immunosuppression |
| 02/22/2000 | US6028096 Parasiticidal pyrazoles |
| 02/22/2000 | US6028095 Treatment of inflammatory bowel disease using histamine H3 -receptor agonists |
| 02/22/2000 | US6028094 Comprising thromboxane synthetase inhibitor ozagrel or its salt for supressing dry coughing |
| 02/22/2000 | US6028092 Salts of N-(4-Oxo-2-(1H-tetrazoyl-5-yl)-4H-1-benzopyran-8-yl)-4-(4-phenylbutoxy)b enzamide |
| 02/22/2000 | US6028091 Medicament |
| 02/22/2000 | US6028090 Adhesion receptor antagonists III |
| 02/22/2000 | US6028086 Selective inhibitors of phosphodiesterase (pde) type iv or production of tumor necrosis factor (tnf) and as such are useful treatment of asthma, arthritis, bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis |
| 02/22/2000 | US6028084 Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives |
| 02/22/2000 | US6028082 For trating psychological disorders |
| 02/22/2000 | US6028081 Substituted quinolone derivatives and pharmaceuticals containing the same |
| 02/22/2000 | US6028080 For treating neurological disorders |
| 02/22/2000 | US6028079 Condensed-indan derivatives and pharmaceutically acceptable salts thereof |
| 02/22/2000 | US6028078 For trating cancer |
| 02/22/2000 | US6028077 For treating mammalian tumor selected from leukemia, lung carcinoma, colon carcinoma and melanoma by administering to said patient antitumor crambescidin compounds |
| 02/22/2000 | US6028075 Administering pharmaceutically effective amount of a compound for treatment of tumor sensitive to the compound |
| 02/22/2000 | US6028074 Pyrazolo[3,4-d]pyrimidineone compounds |
| 02/22/2000 | US6028073 For treating psychoses |
| 02/22/2000 | US6028072 For treating inflammation and inflammation related disorders |
| 02/22/2000 | US6028071 Purified compositions of 10-propargyl-10-deazaaminopterin and methods of using same in the treatment of tumors |